When was Psylo founded?

Psylo was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Psylo located?

Psylo is headquartered in Sydney, Australia.

Who is the current CEO of Psylo?

Josh Ismin of Psylo. They have also founded 1 company.

Which legal entities is Psylo associated with?

Psylo is associated with PSYLO PTY LTD.

How many employees does Psylo have?

As of Mar 01, 2026, the latest employee count at Psylo is 10 - 49.

Is Psylo a funded company?

Psylo is a funded company, having raised a total of $14.2M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 01, 2021.

When was the latest funding round of Psylo?

Psylo's latest funding was a $***** Seed round on Jun 03, 2024, with participation from 5 investors. Its primary sector is Neurology. In Australia, the Neurology sector has seen $17.3M in funding in 2026 to date.

Where does Psylo rank among its competitors?

Psylo ranks 12th amongst 31 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Psilera, which secured $8.8M in May, 2026.

Who are the top competitors of Psylo?

Psylo's top competitors include COMPASS Pathways, MindMed and Gilgamesh. Among them, Psilera secured the most recent funding round in May, 2026.

Psylo - 2026 Company Profile, Team, Funding & Competitors

Psylo is a seed company based in Sydney (Australia), founded in 2021 by Josh Ismin and Sam Banister. It operates as a Developer of psychedelic derived therapeutic for mental illness. Psylo has raised $14.2M in funding from Tenmile and Main Sequence. The company has 31 active competitors, including 10 funded and 14 that have exited. Its top competitors include companies like COMPASS Pathways, MindMed and Gilgamesh.

Company Details

Developer of psychedelic derived therapeutic for mental illness. It provides psychedelics drugs that are improved treatments against selective serotonin reuptake inhibitors (SSRI) medications, allowing patients to recover from severe mental illness like treatment-resistant depression, anxiety, addiction, and others.

Website: psylo.bio
Social

Key Metrics

Founded Year

2021

Location

Sydney, Australia

Stage

Seed

Total Funding

$14.2M in 3 rounds

Latest Funding Round

Seed, Jun 03, 2024, $*****

Investors

Tenmile & 14 more

Ranked

12^th among 31 active competitors

Employee Count

10 - 49 as on Mar 01, 2026

Similar Companies

COMPASS Pathways & 37 more

View Psylo's full profile

Psylo is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PSYLO PTY LTD CIN: 651632772 , Australia, Active	Jul 01, 2021	-	-

Psylo has raised a total funding of $14.2M over 3 rounds. Its first funding round was on Oct 01, 2021. Its latest funding round was a Seed round on Jun 03, 2024 for $*****. 5 investors participated in its latest round. Psylo has 14 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Psylo:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 03, 2024	6258429	Seed	8171264	9292338	5414426	5641188
Oct 27, 2022	1818040	Seed	1256645	4921969	8159311	Lionheart Ventures & 3 more
Oct 01, 2021	5861405	Seed	3606864	2165769	5716516	Possible Ventures & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Psylo's funding rounds and investors

The founders of Psylo are Josh Ismin and Sam Banister. Josh Ismin is the CEO of Psylo.

Here are the details of Psylo's key team members:

Josh Ismin: Co-Founder & CEO of Psylo.
Sam Banister: Co-Founder of Psylo.

View details of Psylo's Founder profiles and Board Members

Psylo's employee count trend

Psylo has 10 - 49 employees as of Mar 26. Here is Psylo's employee count trend over the years:

Uncover Psylo's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Psylo include COMPASS Pathways, MindMed and Gilgamesh. Here is the list of Top 10 competitors of Psylo, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	COMPASS Pathways 2016, London (United Kingdom), Public	Developer of therapies for treating mental disorders	$109M	Perceptive Advisors, Soleus Capital & 20 others	65/100
2nd	MindMed 2019, New York City (United States), Public	Developer of psychedelic-based therapies for brain health disorders	-	TR Ventures, K2 HealthVentures & 9 others	58/100
3rd	Gilgamesh 2019, New York City (United States), Series B	Developer of drugs for neuropsychiatric conditions	$152M	Prime Movers Lab, Satori Capital & 18 others	57/100
4th	Cybin 2002, Toronto (Canada), Public	Provider of psychedelic therapeutics for psychiatric disorders	-	Hightrailcapital, Subversive Capital & 10 others	56/100
5th	Delix Therapeutics 2019, Menlo Park (United States), Series A	Developer of therapeutic solutions for the treatment of multiple neurological disorders	$100M	RA Capital Management, Artis Ventures & 22 others	55/100
6th	Neural Therapeutics 2020, Toronto (Canada), Public	Developer of ethnobotanical drug for neurological disorder	$495K	-	48/100
7th	Psilera 2019, Tampa (United States), Seed	Manufacturer of natural-based medicines for the treatment of mental health illnesses	$11.3M	Iter Investments, What If Ventures & 3 others	48/100
8th	Tryp Therapeutics 2020, Kelowna (Canada), Public	Developer of therapeutic solutions for treating neuropsychiatric disorders & pain	-	-	48/100
9th	Psyence 1997, Toronto (Canada), Public	Developer of psychedelic therapeutics for mental health disorders	-	-	47/100
10th	Eleusis 2013, London (United Kingdom), Acquired	Developer of immunomodulatory and neuroprotective medicines	$1.47M	Palo Santo, Noetic Psychedelic Fund & 4 others	46/100
12th	Psylo 2021, Sydney (Australia), Seed	Developer of psychedelic derived therapeutic for mental illness	$14.2M	Palo Santo, Gaingels & 13 others	44/100